Wednesday, July 20, 2016

BRIEF-Janssen says Health Canada approves Imbruvica for treatment of chronic lymphocytic leukemia

* Health Canada approves Imbruvica (ibrutinib) for

first-line treatment of chronic lymphocytic leukemia

Source text for Eikon:

Further company coverage:

(Bengaluru Newsroom: +1-646-223-8780)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)